MASTROPASQUA, Mauro Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 5.367
AS - Asia 2.448
EU - Europa 1.474
SA - Sud America 755
AF - Africa 95
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 2
Totale 10.148
Nazione #
US - Stati Uniti d'America 5.258
SG - Singapore 1.169
BR - Brasile 619
HK - Hong Kong 363
CN - Cina 332
IT - Italia 265
SE - Svezia 264
FR - Francia 232
RU - Federazione Russa 205
DE - Germania 136
VN - Vietnam 128
GB - Regno Unito 113
IN - India 102
AR - Argentina 48
CA - Canada 47
FI - Finlandia 47
BD - Bangladesh 42
IQ - Iraq 39
UA - Ucraina 35
MX - Messico 34
ID - Indonesia 31
TR - Turchia 31
BE - Belgio 26
AT - Austria 23
ZA - Sudafrica 23
CO - Colombia 20
ES - Italia 20
VE - Venezuela 20
PK - Pakistan 19
MY - Malesia 18
SA - Arabia Saudita 18
JP - Giappone 17
PL - Polonia 17
KR - Corea 16
PH - Filippine 16
UZ - Uzbekistan 16
CL - Cile 15
EC - Ecuador 15
NL - Olanda 15
IE - Irlanda 14
NP - Nepal 14
JO - Giordania 10
MA - Marocco 10
DZ - Algeria 9
EG - Egitto 9
IR - Iran 9
AE - Emirati Arabi Uniti 8
KE - Kenya 7
PY - Paraguay 7
RO - Romania 7
TN - Tunisia 7
DO - Repubblica Dominicana 6
HR - Croazia 6
IL - Israele 6
KZ - Kazakistan 6
OM - Oman 6
RS - Serbia 6
AL - Albania 5
AU - Australia 5
CI - Costa d'Avorio 5
LT - Lituania 5
AZ - Azerbaigian 4
BG - Bulgaria 4
CZ - Repubblica Ceca 4
ET - Etiopia 4
LB - Libano 4
NI - Nicaragua 4
PE - Perù 4
SN - Senegal 4
BO - Bolivia 3
CR - Costa Rica 3
DK - Danimarca 3
EE - Estonia 3
HU - Ungheria 3
JM - Giamaica 3
KW - Kuwait 3
MD - Moldavia 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
UY - Uruguay 3
BB - Barbados 2
BN - Brunei Darussalam 2
GE - Georgia 2
KG - Kirghizistan 2
MN - Mongolia 2
MU - Mauritius 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PA - Panama 2
PS - Palestinian Territory 2
QA - Qatar 2
RE - Reunion 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
ZM - Zambia 2
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
BJ - Benin 1
Totale 10.123
Città #
Chandler 579
Fairfield 571
Singapore 566
Ashburn 550
Hong Kong 362
San Jose 320
Woodbridge 277
Houston 271
Seattle 250
Wilmington 221
Nyköping 205
Cambridge 198
Ann Arbor 134
Lawrence 112
Lauterbourg 111
Beijing 106
Roxbury 91
Los Angeles 82
New York 80
Des Moines 70
Dallas 63
Council Bluffs 60
Jacksonville 57
Santa Clara 53
Paris 51
The Dalles 50
Columbus 47
Bari 45
São Paulo 44
Ho Chi Minh City 41
San Diego 40
Buffalo 32
London 32
Princeton 32
Frankfurt am Main 31
Munich 29
Hanoi 28
Nanjing 28
Nuremberg 28
Brussels 26
Cressa 24
Pune 24
Moscow 23
Helsinki 22
Falls Church 21
Rio de Janeiro 21
Belo Horizonte 20
Brooklyn 20
Chicago 20
Milan 19
Inglewood 18
Tokyo 17
Boardman 15
Baghdad 14
Brasília 14
Dearborn 14
Toronto 14
Washington 14
Amsterdam 13
Atlanta 13
Dublin 13
Jakarta 13
San Mateo 13
Tashkent 13
Warsaw 13
Denver 12
Vienna 12
Boston 11
Chennai 11
Edinburgh 11
Istanbul 11
Montreal 11
Curitiba 10
Kathmandu 10
Seoul 10
Ardabil 9
Kuala Lumpur 9
Leawood 9
Recife 9
Stockholm 9
Campinas 8
Dhaka 8
Johannesburg 8
Madrid 8
Mexico City 8
Porto Alegre 8
San Francisco 8
Santiago 8
Amman 7
Augusta 7
Cuiabá 7
Düsseldorf 7
Guangzhou 7
Hebei 7
Hounslow 7
Jeddah 7
New Delhi 7
Orem 7
Falkenstein 6
Mumbai 6
Totale 6.698
Nome #
Analytical validation of a standardized scoring protocol for Ki67: Phase 3 of an international multicenter collaboration 219
How reliable is Ki-67 immunohistochemistry in grade 2 breast carcinomas? A QA study of the Swiss working group of breast- and gynecopathologists 211
Vascular density and inflammatory infiltrate in primary oral squamous cell carcinoma and after allogeneic hematopoietic stem cell transplantation 176
A risk score based on histopathological features predicts higher risk of distant recurrence in premenopausal patients with lymph node-negative endocrine-responsive breast cancer 174
Inflammatory cells infiltrate and angiogenesis in locally advanced and metastatic cholangiocarcinoma 165
Adenomyoepithelioma 159
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial 147
A new technique for foetal brain fixation and extraction 135
Tumore a Cellule del Sertoli a Grandi Cellule Calcificante (TCSGCC) ad evoluzione maligna. Studio di un caso. 131
Angiosarcoma and atypical vascular lesions of the breast: diagnostic and prognostic role of MYC gene amplification and protein expression 117
Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial 115
A nomogram based on the expression of Ki-67, steroid hormone receptors status and number of chemotherapy courses to predict pathological complete remission after preoperative chemotherapy for breast cancer 115
Abstract S4-6: An international Ki67 reproducibility study 113
Abstract P5-02-01: Analytical validation and prognostic potential of an automated digital scoring protocol for Ki67: An International Ki67 Working Group study 112
An international study to increase concordance in Ki67 scoring 109
Microscopic esophagitis and Barrett in endoscopy-negative gastroesophageal reflux disease (GERD) 108
BETA-GALACTOSYLCERAMIDASE PROMOTES MELANOMA GROWTH VIA MODULATION OF CERAMIDE METABOLISM 108
Angiomixoma aggressivo dello scroto. Studio di un caso 107
Accelerated partial breast irradiation with intraoperative electrons: Using GEC-ESTRO recommendations as guidance for patient selection 107
Analytical validation of a standardised scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicentre collaboration 102
Abstract P5-07-02: Systematic analysis and modulation of Ki67 interobserver variance in 9069 patients from three clinical trials – How much pathologist concordance is needed for meaningful biomarker results? 101
Correlation of size and focality with prognosis in small breast carcinoma: a single institution case series 101
Analytical validation of a standardized scoring protocol for Ki67: Phase-3 of an international multicenter collaboration 100
Testicular Modification Induced by Low Alcohol Intake in Rat. Morphometric Investigations and bcl-2 Oncogene Expression 99
Pathological complete response after preoperative systemic therapy and outcome: Relevance of clinical and biologic baseline features 99
Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer. Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy 98
Peri-Prostatic Epidermal Inclusion Cyst: A Case Report 98
Analytical validation of a standardized scoring protocol for Ki67 assessed on breast excision whole sections: An international multicenter collaboration 97
Paget's disease as a local recurrence after nipple-sparing mastectomy: Clinical presentation, treatment, outcome, and risk factor analysis 97
An international ki67 reproducibility study 96
Regulation of mRNA and protein levels of beta 1 integrin variants in human prostate carcinoma 95
Mechanical characterization of human urethra 95
Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer 94
Ectopic breast tissue as a possible cause of false-positive axillary sentinel lymph node biopsies 93
Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer 93
Intra-Cystic (In Situ) Mucoepidermoid Carcinoma: A Clinico-Pathological Study of 14 Cases 92
Microbiopsia mammaria stereotassica. 91
Final 10-year results of the Breast International Group 2-98 phase III trial and the role of Ki67 in predicting benefit of adjuvant docetaxel in patients with oestrogen receptor positive breast cancer 90
Atypical Ductal Hyperplasia after Vacuum-Assisted Breast Biopsy: Can We Reduce the Upgrade to Breast Cancer to an Acceptable Rate? 90
null 88
Survival outcomes in breast cancer patients with low estrogen/progesterone receptor expression 88
Abstract P1-15-06: Lobular histology and partial breast irradiation: To what extent is it a cautionary parameter? 88
Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes 88
How do the ASTRO consensus statement guidelines for the application of accelerated partial breast irradiation fit intraoperative radiotherapy? A retrospective analysis of patients treated at the European Institute of Oncology 87
Primary and secondary angiosarcomas of the breast: A single institution experience 87
Traditional molecular markers and response to adjuvant endocrine or trastuzumab-based therapies 86
Prognostic value of Ki-67 labeling index in patients with node-negative, triple-negative breast cancer 86
Sensitivity and Detection Rate of a 12-Core Trans-Perineal Prostate Biopsy: Preliminary Report 86
Basaloid cell carcinoma of the prostate. Case report and review of the literature 86
Heterogeneity of triple-negative breast cancer: Histologic subtyping to inform the outcome 85
Mammary stereotaxic core-biopsy by Mammotome: an alternative to frozen section examination 84
Wireless ultrasound-guided vacuum-assisted breast biopsy: Experience in clinical practice at European Institute of Oncology 84
Malignant Large Cell Calcifying Sertoli Cell Tumor of the Testis (LCCSCTT). Report of a case in an elderly man and review of the literature 83
Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial 83
Progesterone receptor loss identifies luminal B breast cancer subgroups at higher risk of relapse 83
Positive axillary sentinel lymph node: Is axillary dissection always necessary? 83
Immunoreactivity for c-kit and p63 as an adjunct in the diagnosis of adenoid cystic carcinoma of the breast 83
Complete removal of the lesion as a guidance in the management of patients with breast ductal carcinoma in Situ 83
Outcome of special types of luminal breast cancer 82
Breast cancer subtypes and outcome after local and regional relapse 81
What can the pathologist offer for optimal treatment choice? 81
MUC1 Tissue Expression and Its Soluble Form CA15-3 Identify a Clear Cell Renal Cell Carcinoma with Distinct Metabolic Profile and Poor Clinical Outcome 81
Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy 80
High Ki67 predicts unfavourable outcomes in early breast cancer patients with a clinically clear axilla who do not receive axillary dissection or axillary radiotherapy 80
Mesotelioma multicistico benigno del pericardio. Descrizione di un caso 78
COVID-19 And Breast Fine Needle Aspiration Cytology Method: What Should We Change? 78
Clinicopathological and immunohistochemical study of 30 cases of post-radiation atypical vascular lesion of the breast 77
Clinical and pathological assessment of high-risk ductal and lobular breast lesions: What surgeons must know 77
Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes 76
Metastatic tumors of the oro-facial tissues: Clear cell renal cell carcinoma. A clinico-pathological study of seven cases 75
Immunohistochemically defined subtypes and outcome in occult breast carcinoma with axillary presentation 75
Risk of locoregional recurrence in patients with false-negative frozen section or close margins of retroareolar specimen in nipple-sparing mastectomy 74
Osteoclast-like stromal giant cells in invasive ductal breast cancer: A case series 74
A New Possible Cut-Off of Cytokeratin 19 mRNA Copy Number by OSNA in the Sentinel Node of Breast Cancer Patients to Avoid Unnecessary Axillary Dissection: A 10-Year Experience in a Tertiary Breast Unit 73
Benign multicystic mesothelioma of the pericardium (BMMP). A case report 73
Pathologic examination of the axillary sentinel lymph nodes in patients with early-stage breast carcinoma: Current and resolving controversies on the basis of the European Institute of Oncology experience 73
Breast cancer subtypes and outcome after local and regional relapse 73
Prognostic significance of Ki-67 in node-negative (pN0), triple-negative (TN) breast cancer (BC) 73
Evaluation of computer-aided diagnosis in breast ultrasonography: Improvement in diagnostic performance of inexperienced radiologists 73
HER2-negative (1+) breast cancer with unfavorable prognostic features: To FISH or not to FISH? 72
p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer 71
Outcome and medial presentation of breast cancer: European Institute of Oncology experience 71
The prognostic role of high Ki-67 in early breast cancer patients who do not receive axillary dissection or axillary radiotherapy 71
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): A phase 3 randomised controlled trial 70
Advances and controversies in management of breast ductal carcinoma in situ (DCIS) 70
Changes in PgR and Ki-67 in residual tumour and outcome of breast cancer patients treated with neoadjuvant chemotherapy 69
Atypical vascular lesions after radiation therapy for breast cancer: A clinicopathologic study and outcomes of 24 cases 68
Changes in PgR and Ki-67 in residual tumour and outcome of breast cancer patients treated with neoadjuvant chemotherapy 68
Comparison of Treatment Outcome Between Invasive Lobular and Ductal Carcinomas in Patients Receiving Partial Breast Irradiation With Intraoperative Electrons 67
Randomized controlled trial of bromelain and alpha-lipoic acid in breast conservative surgery 66
TEN-YEAR SAFETY AND EFFICACY ANALYSES OF THE BIG 02-98 PHASE III TRIAL WITH AN EXPLORATORY ANALYSIS ON THE ROLE OF KI67 IN PREDICTING BENEFIT OF ADJUVANT DOCETAXEL IN ER POSITIVE PATIENTS 66
Robotic vs open prostatectomy in a laparoscopically naive centre: A matched-pair analysis 65
Male breast cancer 65
Calcified metastatic mediastinal lymph nodes from mucinous breast adenocarcinoma 64
Breast cancer pathology 64
Occasional finding of a carcinoid in a vermiform appendix-like structure inside a mature cystic teratoma of the ovary 64
β3 adrenergic receptor as potential therapeutic target in ADPKD 64
Studio delle regioni organizzatrici argirofile del nucleolo (AgNORs) nelle neoformazioni colo-rettali quale indice di malignità biologica. [Argyrophilic nucleolar organizer regions (AgNORs) as malignancy biomarkers in colorectal neoplasms]. 63
Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes 63
Primary Breast Extranodal Marginal Zone Lymphoma in Primary Sjögren Syndrome: Case Presentation and Relevant Literature 63
Totale 9.181
Categoria #
all - tutte 53.031
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.031


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021373 0 0 0 0 0 0 0 0 0 158 82 133
2021/2022692 36 25 1 19 55 110 13 36 40 95 52 210
2022/20231.466 154 149 91 147 105 190 50 234 207 20 95 24
2023/2024525 41 84 34 24 51 121 21 42 3 14 35 55
2024/20251.998 17 34 159 90 106 214 172 139 136 139 285 507
2025/20263.367 585 207 172 292 493 241 497 123 411 346 0 0
Totale 10.591